Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
Grow DA, McCarrey JR, Navara CS. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease. Stem Cell Res. 2016 09; 17(2):352-366.